Home » Archive by Category

News

Original content and news from BioSpace, Xconomy, Marketwire and other sources, specific to the region.

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

August 7, 2014 – 8:31 am | Edit Post
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

August 7, 2014 – 8:31 am | Edit Post
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

August 7, 2014 – 8:31 am | Edit Post
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

August 7, 2014 – 8:31 am | Edit Post
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More

The IPO window is still open, sort of, but life sciences companies are not getting through unscathed. San Francisco-based Tobira Therapeutics and New York’s Microlin Bio postponed their offerings…

[[Click headline to continue reading.]]

Ebola treatment raises ethical issues

August 6, 2014 – 7:15 pm | Edit Post

The emergency treatment of two Ebola-infected American health workers with an experimental drug developed by a San Diego company is raising thorny ethical and practical questions about what to do for others stricken with the disease.

Stephen F. Heinemann, pioneering Salk neuroscientist, dies at 75

August 6, 2014 – 5:00 pm | Edit Post

Stephen F. Heinemann, whose pioneering research on neurotransmitter receptors in the brain helped lay the groundwork for understanding diseases of the brain, died August 6 of complications of kidney failure at Vibra Hospital in San Diego, California….

Longtime vision leads to Ebola serum

August 6, 2014 – 7:01 am | Edit Post

Mapp focuses on public-health diseases given short shrift by larger companies.

“Glee” star Matthew Morrison headlines Symphony at Salk, August 23

August 5, 2014 – 5:00 pm | Edit Post

LA JOLLA–Tickets are on sale now for the Salk Institute’s 19th Annual Symphony at Salk, one of the summer’s premiere events, taking place on Saturday, August 23. The annual musical affair features the highly regarded San Diego Symphony along with Emmy, Tony and Golden Globe-nominated star Matthew Morrison.

UCSD, The Scripps Research Institute and Illumina Get NIH Grants

August 5, 2014 – 4:06 pm | Edit Post

The Scripps Research Institute, the University of California, San Diego and Illumina Inc. have been awarded a total of $8.7 million in grants by the National Institutes of Health for DNA sequencing research.

San Diego Pharmaceutical Company Behind Ebola Medicine | NBC 7 San Diego

August 5, 2014 – 1:52 pm | Edit Post

San Diego Pharmaceutical Company Behind Ebola Medicine | NBC 7 San Diego.